[1]Liang E, Brown B, Kirsop R, et a1. Efficacy of uterine artery embolisation for treatment of symptomatic fibroids and adenomyosis: an interim reporton an Australian experience[J]. Aust N Z J 0bstet Gynaecol, 2012, 52: 106-112.
[2]Torre A, Paillusson B, Fain V, et al. Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms[J]. Hum Reprod, 2014, 29: 490-501.
[3]Ouyang Z, Liu P, Yu Y, et al. Role of ovarian artery-to-uterine artery anastomoses in uterine artery embolization: initial anatomic and radiologic studies[J]. Surg Radiol Anat, 2012, 34: 737-741.
[4]陈春林, 徐玉静, 刘萍, 等. 子宫肌瘤数字化三维动脉血管网的构建和意义[J]. 介入放射学杂志, 2012, 21: 35-39.
[5]Salazar GM, Gregory-Walker T, Conway RF, et al. Embolization of angiographically visible type Ⅰ and Ⅱ utero-ovarian anastomoses during uterine artery embolization for fibroid tumors: impact on symptom recurrence and permanent amenorrhea[J]. J Vasc Interv Radiol, 2013, 24; 1347-1352.
[6]Smoger DL, Kancherla V, Shlansky-Goldberg RD. Uterine fhndal b1ood supply from an aberrant left ovarian artery originating from the inferior mesenteric artery: implications for uterine artery embolization[J]. J Vasc Interv Radiol, 2010, 2l: 94l-944.
[7]Hu NN, Kaw D, McCullough MF, et al. Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls[J]. J Vasc Interv Radiol, 2011, 22: 710-715.
[8]Scheurig-Muenkler C, Poellinger A, Wagner M, et al. Ovarian artery embolization in patients with collateral supply to symptomatic uterine leiomyomata[J]. Cardiovasc Intervent Radiol, 2011, 34: 1199-1207.